ABSTRACT
In August 2018, a fatal autochthonous case of Crimean-Congo hemorrhagic fever was confirmed in western Spain. The complete sequence of the viral genome revealed circulation of a new virus because the genotype differs from that of the virus responsible for another case in 2016. Practitioners should be alert to possible new cases.
Subject(s)
Hemorrhagic Fever Virus, Crimean-Congo , Hemorrhagic Fever, Crimean , Genome, Viral , Hemorrhagic Fever Virus, Crimean-Congo/genetics , Humans , Reassortant Viruses , SpainABSTRACT
OBJECTIVES: Darunavir/ritonavir (DRV/r) in mono or dual therapy has proven efficacy in selected patients. The aim of this study was to evaluate the efficacy of switching from DRV/r to DRV/cobicistat (DRV/c) in patients under mono or dual therapy. METHODS: This was a prospective multicenter cohort study of patients using DRV/r under mono or dual therapy plus lamivudine who changed to DRV/c maintaining the previous regimen. All patients had a controlled HIV viral load (<50 copies/ml) when switched and were examined every 12 weeks. The primary end-point was the percentage of participants without virological failure (VF) at week 48 in the intent-to-treat analysis. The CD4 cell count and concentrations of cholesterol, triglyceride, and creatinine were measured from baseline to week 48. RESULTS: A total of 162 patients were included: 68.5% were men, and their mean age was 46 ± 12 years. Seventy (43.2%) patients were treated with DRV/r monotherapy, and 92 (56.8%) were treated with DRV/r plus lamivudine. The efficacy at week 48 was 95.1% (95% CI: 90.6%-97.5%) in the intent-to-treat analysis and 98.7% (95.5-99.6%) in the on-treatment analysis. Two VFs were documented but without development of resistance mutations. No significant changes were found in the lipid profile. Creatinine concentration increased significantly by 0.07 mg/dl (0.04-0.10, P < 0.001). CONCLUSIONS: Switching from DRV/r to DRV/c in patients under mono or dual therapy is safe and effective.
Subject(s)
Cobicistat/therapeutic use , Darunavir/therapeutic use , HIV Infections/drug therapy , Ritonavir/therapeutic use , Adult , Cobicistat/administration & dosage , Cohort Studies , Darunavir/administration & dosage , Drug Therapy, Combination , Female , Humans , Male , Middle Aged , Prospective Studies , Ritonavir/administration & dosage , Viral LoadABSTRACT
BACKGROUND: Random safety audits (RSA) are a safety tool enabling prevention of adverse events, but they have not been widely used in hospitals. The aim of this study was to use RSAs to assess and compare the frequency of appropriate use of infusion pump safety systems in a Neonatal Intensive Care Unit (NICU) before and after quality improvement interventions and to analyse the intravenous medication programming data. METHODS: Prospective, observational study comparing the frequency of appropriate use of Alaris® CC smart pumps through RSAs over two periods, from 1 January to 31 December 2012 and from 1 November 2014 to 31 January 2015. Appropriate use was defined as all evaluated variables being correctly programmed into the same device. Between the two periods they were established interventions to improve the use of pumps. The information recorded at the pumps with the new security system, also extracted for one year. RESULTS: Fifty-two measurements were collected during the first period and 160 measurements during the second period. The frequency of appropriate use was 73.13 % (117/160) in the second period versus 0 % (0/52) in the first period (p < 0.0001). Information was recorded on 44,924 infusions; in 46.03 % (20,680/44,924) of cases the drug name was recorded. In 2.5 % (532/20,680) of cases there was an attempt to exceed the absolute limit. CONCLUSIONS: Random Safety Audits were a very useful tool for detecting inappropriate use of pumps in the NICU. The improvement strategies were effective for improving appropriate use and programming of the intravenous medication infusion pumps in our NICU.
Subject(s)
Infusion Pumps , Intensive Care Units, Neonatal/standards , Medical Audit , Patient Safety/standards , Humans , Infant, Newborn , Medication Systems, Hospital/standards , Prospective Studies , Quality Improvement , Safety ManagementABSTRACT
BACKGROUND: Random safety audits (RSAs) are a safety tool but have not been widely used in hospitals. OBJECTIVES: To determine the frequency of proper use of equipment safety mechanisms in relation to monitoring and mechanical ventilation by performing RSAs. The study also determined whether factors related to the patient, time period, or characteristics of the area of admission influenced how the device safety systems were used. METHODS: A prospective observational study was conducted in a level III-C Neonatal Intensive Care Unit (NICU) during 2012. 87 days were randomly selected. Appropriate overall use was defined when all evaluated variables were correctly programmed in the audited device. RESULTS: A total of 383 monitor and ventilator audits were performed. The Kappa coefficient of interobserver agreement was 0.93. The rate of appropriate overall use of the monitors and respiratory support equipment was 33.68%. Significant differences were found with improved usage during weekends, OR 1.85 (1.12-3.06, p = 0.01), and during the late shift (3 pm to 10 pm), OR 1.59 (1.03-2.4, p = 0.03). CONCLUSIONS: Equipment safety systems of monitors and ventilators are not properly used. To improve patient safety, we should identify which alarms are really needed and where the difficulties lie for the correct alarm programming.
Subject(s)
Intensive Care Units, Neonatal/standards , Monitoring, Physiologic/instrumentation , Monitoring, Physiologic/standards , Respiration, Artificial/instrumentation , Respiration, Artificial/standards , Clinical Audit , Humans , Infant, Newborn , Patient Safety , Prospective StudiesABSTRACT
BACKGROUND: Lysosomal acid lipase is an essential lipid-metabolizing enzyme that breaks down endocytosed lipid particles and regulates lipid metabolism. We conducted a phase 3 trial of enzyme-replacement therapy in children and adults with lysosomal acid lipase deficiency, an underappreciated cause of cirrhosis and severe dyslipidemia. METHODS: In this multicenter, randomized, double-blind, placebo-controlled study involving 66 patients, we evaluated the safety and effectiveness of enzyme-replacement therapy with sebelipase alfa (administered intravenously at a dose of 1 mg per kilogram of body weight every other week); the placebo-controlled phase of the study was 20 weeks long and was followed by open-label treatment for all patients. The primary end point was normalization of the alanine aminotransferase level. Secondary end points included additional disease-related efficacy assessments, safety, and side-effect profile. RESULTS: Substantial disease burden at baseline included a very high level of low-density lipoprotein cholesterol (≥190 mg per deciliter) in 38 of 66 patients (58%) and cirrhosis in 10 of 32 patients (31%) who underwent biopsy. A total of 65 of the 66 patients who underwent randomization completed the double-blind portion of the trial and continued with open-label treatment. At 20 weeks, the alanine aminotransferase level was normal in 11 of 36 patients (31%) in the sebelipase alfa group and in 2 of 30 (7%) in the placebo group (P=0.03), with mean changes from baseline of -58 U per liter versus -7 U per liter (P<0.001). With respect to prespecified key secondary efficacy end points, we observed improvements in lipid levels and reduction in hepatic fat content (P<0.001 for all comparisons, except P=0.04 for triglycerides). The number of patients with adverse events was similar in the two groups; most events were mild and were considered by the investigator to be unrelated to treatment. CONCLUSIONS: Sebelipase alfa therapy resulted in a reduction in multiple disease-related hepatic and lipid abnormalities in children and adults with lysosomal acid lipase deficiency. (Funded by Synageva BioPharma and others; ARISE ClinicalTrials.gov number, NCT01757184.).
Subject(s)
Sterol Esterase/therapeutic use , Wolman Disease/drug therapy , Adolescent , Adult , Aged , Alanine Transaminase/blood , Biopsy , Child , Child, Preschool , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Double-Blind Method , Dyslipidemias/drug therapy , Dyslipidemias/genetics , Female , Humans , Liver/drug effects , Liver/pathology , Male , Middle Aged , Sterol Esterase/adverse effects , Sterol Esterase/pharmacology , Wolman Disease/blood , Young Adult , Wolman DiseaseABSTRACT
A blood sample from a 14-year-old dog was submitted to the veterinary diagnostic laboratory of the University of Milan for marked leukocytosis with atypical cells. A diagnosis of chronic T-cell lymphocytic leukemia (CLL) was made based on blood smear evaluation and flow cytometric phenotyping. A CBC by Sysmex XT-2000iV revealed a moderate normocytic normochromic anemia. Red blood cells counted by optic flow cytometry (RBC-O) resulted in a higher value than using electrical impedance (RBC-I). The relative reticulocyte count based on RNA content and size was 35.3%, while the manual reticulocyte count was < 1%. The WBC count of 1,562,680 cells/µL was accompanied by a flag. Manual counts for RBC and WBC using the Bürker chamber confirmed the Sysmex impedance results. Finally the manual PCV was lower than HCT by Sysmex. While Sysmex XT can differentiate between RBC and WBC by impedance, even in the face of extreme lymphocytosis due to CLL, RBC-O can be affected by bias, resulting in falsely increased RBC and reticulocyte numbers. Overestimation of RBC-O may be due to incorrect Sysmex classification of leukemic cells or their fragments as reticulocytes. This phenomenon is known as pseudoreticulocytosis and can lead to misinterpretation of regenerative anemia. On the other side PCV can be affected by bias in CLL due to the trapping of RBC in the buffy coat, resulting in a pink hue in the separation area. As HGB concentration is not affected by flow cytometric or other cell-related artifacts it may represent the most reliable variable to assess the degree of anemia in cases of CLL.
Subject(s)
Dog Diseases/diagnosis , Leukemia, Lymphocytic, Chronic, B-Cell/veterinary , Leukocytosis/veterinary , Animals , Blood Chemical Analysis/veterinary , Dog Diseases/blood , Dogs , Erythrocyte Count/instrumentation , Erythrocyte Count/veterinary , Hematology , Leukemia, Lymphocytic, Chronic, B-Cell/blood , Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis , Leukocyte Count/instrumentation , Leukocyte Count/veterinary , Leukocytosis/blood , Leukocytosis/diagnosis , Male , Phenotype , Reticulocyte Count/instrumentation , Reticulocyte Count/veterinaryABSTRACT
Este artículo se basa en una recolección bibliográfica que explora el tema de "Implantación de Memorias ó Memorias Falsas". Los cuestionamientos constantes a las víctimas de traumas, especialmente aquellos que conllevan una agresión sexual, ha sido uno de los temas que más trae polémicas en las cortes. Los ataques a los recuerdos y la credibilidad de los relatos de las víctimas es el tema central de tales cuestionamientos. Estos ataques incluyen no solo a la misma víctima, sino también a terapeutas, maestros, entrevistadores y hasta sus propias madres o abuelos, entre otros; convietiéndose en una necesidad medular actualizarse en el tema. Palabras claves: Memoria, trauma, abuso sexual, memoria traumática, memorias reprimidas, confabulaciones, recuerdos espontáneos, testimonios
Subject(s)
Humans , Aggression/psychology , Child Abuse, Sexual , Memory , Mental Processes , Mental Recall , Repression, Psychology , Costa RicaABSTRACT
El siguiente trabajo científico descriptivo pretende analizar el fenómeno: trastorno de estrés postraumático en adolescentes, en un rango de edad de diez a veinte años, que han sido víctimas de violencia en sus diferentes maneras de expresión. Estos pacientes han sido evaluados en la Sección de Psiquiatría y Psicología Forenses, en el Complejo de Ciencias Forenses en San Joaquín de Flores, Heredia, del primero de noviembre de 2002 al 30 de abril de 2003. Palabras clave: Trastorno de estrés post-traumático, adolescencia, cuadro clínico, criterios diagnósticos, sintomatología, evaluación estadística.
Subject(s)
Humans , Male , Adolescent , Female , Adolescent Behavior , Aggression , Stress Disorders, Post-Traumatic/diagnosis , Stress Disorders, Post-Traumatic/physiopathology , Stress Disorders, Post-Traumatic/psychology , Stress Disorders, Post-Traumatic/therapy , Costa RicaABSTRACT
Fundamento. Estudio retrospectivo de las características clínico epidemiológicas, tratamiento y evolución de 22 enfermos adultos con neumonía por varicela diagnosticados en los últimos cinco años. Material y métodos. El diagnóstico se estableció sobre la base de criterios radiológicos en el curso de una varicela. Se recogieron los datos sobre: embarazo, antecedentes de contacto previo con pacientes con varicela, patología subyacente y hábito de fumar. Resultados. Se estudiaron 22 enfermos, 14 varones y 8 mujeres, con una edad media de 31 años (Rango: 22-40). Ningún paciente era inmunodeprimido, 16 (72,7 por ciento) referían contacto previo con pacientes con varicela, 19 (86,3 por ciento) tenían hábito de fumar y ninguna de las mujeres estaba embarazada. Todos los enfermos tenían fiebre, referían tos seca 20 (90,9 por ciento), disnea 16 (72,7 por ciento), dolor torácico 9 (40,9 por ciento) y hemoptisis 5 (22,7 por ciento). Solamente 2 (9 por ciento) presentaban una pO2 < 60 mmHg. La radiología de tórax presentaba patrón intersticial en 14 casos (63,6 por ciento), y micronodular en 8 (36,3 por ciento). Los 22 pacientes recibieron tratamiento con aciclovir por vía intravenosa. Tres enfermos presentaron fracaso renal reversible en relación con el aciclovir y otros 3 (13,6 por ciento) requirieron ingreso en Unidad de Cuidados Intensivos por insuficiencia respiratoria precisando 1 de ellos (4,5 por ciento) ventilación mecánica. La evolución fue satisfactoria en todos. Conclusiones. La administración precoz de aciclovir por vía intravenosa en adultos con neumonía varicelosa previene el fallo respiratorio progresivo y reduce la alta mortalidad. En enfermos con neumonía grave se debe considerar la asociación de corticoides al tratamiento antivírico. La quimioprofilaxis con aciclovir por vía oral, probablemente, es beneficiosa en la población adulta con varicela. (AU)
